Ignite Creation Date:
2024-05-06 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03647111
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2018-08-23
Brief Title:
Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer
Sponsor:
Organization:
Hunan Province Tumor Hospital